4 results
Approved WMOCompleted
To increase progression-free survival at 3 months.
Approved WMOCompleted
The primary objective of this study is to evaluate efficacy and safety. Secondary objectives: PK, PK-PD.
Approved WMOCompleted
To compare a new endoscopic brush device with conventional brush cytology and compare the amount of cells obtained by the two different brushes
Approved WMOCompleted
Primary: Efficacy of FF/GW642444 100/25 mcg once daily in comparison with that of FP/salmeterol 250/50 mcg twice daily during 24 weeks.Secundary: Safety and tolerability.